Electrospun nanofibrous polymeric scaffold with targeted drug release profiles for potential application as wound dressing.
暂无分享,去创建一个
Joachim Kohn | Rashmi Thakur | J. Kohn | R. Thakur | C. Florek | B. Michniak | Bozena B. Michniak | Charles A. Florek
[1] Arturo Valenzuela,et al. Experimental Studies on the Effect of Lidocaine on Wound Healing , 1998, World Journal of Surgery.
[2] Karthik Nagapudi,et al. Engineered collagen–PEO nanofibers and fabrics , 2001, Journal of biomaterials science. Polymer edition.
[3] R. W. Ross,et al. Rapid, Modified Kirby-Bauer Susceptibility Test with Single, High-Concentration Antimicrobial Disks , 1973, Antimicrobial Agents and Chemotherapy.
[4] J. Mccall,et al. HPLC assay of Lidocaine in plasma with solid phase extraction and UV detection. , 1999, Journal of pharmaceutical and biomedical analysis.
[5] Boyle Vj,et al. Rapid, Modified Kirby-Bauer Susceptibility Test with Single, High-Concentration Antimicrobial Disks , 1973 .
[6] A. Haegerstrand,et al. Ropivacaine and lidocaine inhibit proliferation of non-transformed cultured adult human fibroblasts, endothelial cells and keratinocytes , 1993, Agents and Actions.
[7] Myung-Seob Khil,et al. Electrospun nanofibrous polyurethane membrane as wound dressing. , 2003, Journal of biomedical materials research. Part B, Applied biomaterials.
[8] Kwangsok Kim,et al. Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[9] Lixin Yang,et al. Influence of the drug compatibility with polymer solution on the release kinetics of electrospun fiber formulation. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[10] K. Leong,et al. Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers. , 2006, Biomaterials.
[11] G. Wnek,et al. Electrospinning of poly(ethylene-co-vinyl alcohol) fibers. , 2003, Biomaterials.
[12] S. Santoyo,et al. Development and validation of a liquid chromatographic method for in vitro mupirocin quantification in both skin layers and percutaneous penetration studies. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[13] Joel Rosenblatt,et al. Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[14] J. Siepmann,et al. Hydrophilic Matrices for Controlled Drug Delivery: An Improved Mathematical Model to Predict the Resulting Drug Release Kinetics (the “sequential Layer” Model) , 2004, Pharmaceutical Research.
[15] Yan Li,et al. A facile technique to prepare biodegradable coaxial electrospun nanofibers for controlled release of bioactive agents. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[16] L. Miller,et al. Interpretive criteria for testing susceptibility of staphylococci to mupirocin , 1997, Antimicrobial agents and chemotherapy.
[17] Lixin Yang,et al. Biodegradable electrospun fibers for drug delivery. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[18] Lisbeth Grøndahl,et al. Controlled release of heparin from poly(ε-caprolactone) electrospun fibers , 2006 .
[19] V. Meidan,et al. Enhanced iontophoretic delivery of buspirone hydrochloride across human skin using chemical enhancers. , 2003, International journal of pharmaceutics.
[20] S. Ramakrishna,et al. Electrospinning of nano/micro scale poly(L-lactic acid) aligned fibers and their potential in neural tissue engineering. , 2005, Biomaterials.
[21] Hongliang Jiang,et al. Preparation and characterization of ibuprofen-loaded poly(lactide-co-glycolide)/poly(ethylene glycol)-g-chitosan electrospun membranes , 2004, Journal of biomaterials science. Polymer edition.
[22] Kam W Leong,et al. Sustained release of proteins from electrospun biodegradable fibers. , 2005, Biomacromolecules.
[23] N. Aydın,et al. Antimicrobial activity of ropivacaine and other local anaesthetics , 2001, European journal of anaesthesiology.
[24] Shaobing Zhou,et al. Investigation of drug release and matrix degradation of electrospun poly(DL-lactide) fibers with paracetanol inoculation. , 2006, Biomacromolecules.
[25] Xuesi Chen,et al. Ultrafine medicated fibers electrospun from W/O emulsions. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[26] J. Kohn,et al. Comparison of the effect of ethylene oxide and γ-irradiation on selected tyrosine-derived polycarbonates and poly(L-lactic acid) , 1997 .
[27] E. Entcheva,et al. Electrospun fine-textured scaffolds for heart tissue constructs. , 2005, Biomaterials.
[28] R. Boon,et al. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use , 1985, Antimicrobial Agents and Chemotherapy.
[29] J. Siepmann,et al. HPMC-Matrices for Controlled Drug Delivery: A New Model Combining Diffusion, Swelling, and Dissolution Mechanisms and Predicting the Release Kinetics , 1999, Pharmaceutical Research.
[30] A. Goldstein,et al. Effect of fiber diameter on spreading, proliferation, and differentiation of osteoblastic cells on electrospun poly(lactic acid) substrates. , 2006, Biomaterials.
[31] Won Ho Park,et al. Electrospinning of collagen nanofibers: effects on the behavior of normal human keratinocytes and early-stage wound healing. , 2006, Biomaterials.
[32] Darrell H. Reneker,et al. Beaded nanofibers formed during electrospinning , 1999 .
[33] A. Popescu,et al. Wound Pain: A Challenge for the Patient and the Wound Care Specialist , 2004, Advances in skin & wound care.
[34] John Layman,et al. Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[35] G. Verreck,et al. The use of polymer-based electrospun nanofibers containing amorphous drug dispersions for the delivery of poorly water-soluble pharmaceuticals. , 2004, Die Pharmazie.